Skip to main content
. 2024 Apr 8;15:248–254. doi: 10.18632/oncotarget.28579

Figure 2. Effect of treatment with MIA-602 on the growth of Doxorubicin-resistant K-562 tumors xenographed into nude mice.

Figure 2

After 28 days, treatment with MIA-602 significantly reduced tumor volume compared to the control diluent.